Moors & Cabot, Inc. Novartis Ag Transaction History

Moors & Cabot, Inc.

$1.96 Billion
Q3 2024

A detailed history of Moors & Cabot, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Moors & Cabot, Inc. holds 28,559 shares of NVS stock, worth $2.81 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

28,559

Previous 28,809 0.87%

Holding current value

$2.81 Million

Previous $3.07 Million 7.08%

% of portfolio

0.17%

Previous 0.17%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$106.13 - $120.89 $26,532 - $30,222	-250 Reduced 0.87%	28,559 $3.28 Million
Q2 2024 Aug 09, 2024	SELL	$92.57 - $107.37 $16,940 - $19,648	-183 Reduced 0.63%	28,809 $3.07 Million
Q1 2024 May 08, 2024	SELL	$95.27 - $108.47 $52,398 - $59,658	-550 Reduced 1.86%	28,992 $2.8 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $23,067 - $25,385	250 Added 0.85%	29,542 $2.98 Million
Q3 2023 Nov 07, 2023	BUY	$94.73 - $105.13 $23,682 - $26,282	250 Added 0.86%	29,292 $2.98 Million
Q2 2023 Aug 09, 2023	SELL	$92.52 - $104.91 $92,982 - $105,434	-1,005 Reduced 3.34%	29,042 $2.93 Million
Q1 2023 May 04, 2023	BUY	$80.03 - $92.81 $21,207 - $24,594	265 Added 0.89%	30,047 $2.76 Million
Q4 2022 Feb 09, 2023	BUY	$75.55 - $92.52 $27,198 - $33,307	360 Added 1.22%	29,782 $2.7 Million
Q4 2022 Feb 06, 2023	SELL	$75.55 - $92.52 $113,173 - $138,594	-1,498 Reduced 4.84%	29,422 $2.67 Million
Q3 2022 Nov 07, 2022	SELL	$74.61 - $87.26 $22,159 - $25,916	-297 Reduced 0.95%	30,920 $2.35 Million
Q2 2022 Aug 08, 2022	BUY	$80.52 - $93.75 $20,291 - $23,625	252 Added 0.81%	31,217 $2.64 Million
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $45,101 - $51,019	563 Added 1.85%	30,965 $2.72 Million
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $2.52 Million - $2.78 Million	-31,598 Reduced 50.96%	30,402 $2.66 Million
Q3 2021 Dec 08, 2021	BUY	$81.78 - $95.14 $4.48 Million - $5.21 Million	54,798 Added 760.87%	62,000 $5.05 Million
Q3 2021 Nov 05, 2021	SELL	$81.78 - $95.14 $1.89 Million - $2.2 Million	-23,115 Reduced 76.24%	7,202 $1.22 Million
Q2 2021 Aug 10, 2021	BUY	$85.24 - $94.15 $39,380 - $43,497	462 Added 1.55%	30,317 $2.77 Million
Q1 2021 May 12, 2021	SELL	$83.5 - $98.47 $325,149 - $383,442	-3,894 Reduced 11.54%	29,855 $2.55 Million
Q4 2020 Feb 11, 2021	SELL	$78.07 - $94.43 $21,156 - $25,590	-271 Reduced 0.8%	33,749 $3.19 Million
Q3 2020 Nov 09, 2020	SELL	$82.14 - $91.0 $67,272 - $74,529	-819 Reduced 2.35%	34,020 $2.96 Million
Q2 2020 Aug 13, 2020	BUY	$80.93 - $91.1 $482,342 - $542,956	5,960 Added 20.64%	34,839 $3.04 Million
Q1 2020 May 12, 2020	SELL	$70.67 - $99.01 $604,511 - $846,931	-8,554 Reduced 22.85%	28,879 $2.37 Million
Q4 2019 Jan 28, 2020	SELL	$84.35 - $95.37 $4,133 - $4,673	-49 Reduced 0.13%	37,433 $3.54 Million
Q3 2019 Oct 22, 2019	BUY	$85.54 - $94.26 $117,617 - $129,607	1,375 Added 3.81%	37,482 $3.26 Million
Q2 2019 Jul 18, 2019	BUY	$75.4 - $92.8 $99,000 - $121,846	1,313 Added 3.77%	36,107 $3.3 Million
Q1 2019 May 06, 2019	SELL	$75.32 - $86.15 $2.62 Million - $3 Million	-34,794 Reduced 50.0%	34,794 $3.34 Million
Q1 2019 May 01, 2019	BUY	$75.32 - $86.15 $2.7 Million - $3.09 Million	35,812 Added 106.03%	69,588 $6.68 Million
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $99,882 - $111,219	-1,356 Reduced 3.86%	33,776 $2.9 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $50,271 - $58,149	751 Added 2.18%	35,132 $3.03 Million
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $342,984 - $387,634	-5,284 Reduced 13.32%	34,381 $2.6 Million
Q1 2018 May 18, 2018	SELL	$70.39 - $84.15 $21,961 - $26,254	-312 Reduced 0.78%	39,665 $3.21 Million
Q4 2017 Feb 13, 2018	SELL	$72.33 - $77.64 $90,123 - $96,739	-1,246 Reduced 3.02%	39,977 $3.35 Million
Q3 2017 Nov 16, 2017	BUY	$74.14 - $77.27 $224,495 - $233,973	3,028 Added 7.93%	41,223 $3.55 Million
Q2 2017 Aug 15, 2017	BUY	N/A	38,195	38,195 $3.19 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account